Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea D Olmstead

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|February 4, 2015
Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimationVincent Montoya, Andrea D Olmstead, Naveed Z Janjua, et al.
IEEE Transactions on Medical Imaging|May 27, 2022
DEEMD: Drug Efficacy Estimation Against SARS-CoV-2 Based on Cell Morphology With Deep Multiple Instance LearningM Sadegh Saberian, Kathleen P Moriarty, Andrea D Olmstead, et al.
Scientific Reports|May 12, 2021
Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugsVincent Montoya, Anita Y M Howe, Weiyan Y Dong, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|April 29, 2015
A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission eventsAndrea D Olmstead, Jeffrey B Joy, Vincent Montoya, et al.
Drug and Alcohol Dependence|May 16, 2015
Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, CanadaEvan B Cunningham, Brendan Jacka, Kora DeBeck, et al.
Viruses|November 11, 2022
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort StudyAndrea D Olmstead, Aidan M Nikiforuk, Sydney Schwartz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|February 4, 2015
Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimationVincent Montoya, Andrea D Olmstead, Naveed Z Janjua, et al.
IEEE Transactions on Medical Imaging|May 27, 2022
DEEMD: Drug Efficacy Estimation Against SARS-CoV-2 Based on Cell Morphology With Deep Multiple Instance LearningM Sadegh Saberian, Kathleen P Moriarty, Andrea D Olmstead, et al.
Scientific Reports|May 12, 2021
Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugsVincent Montoya, Anita Y M Howe, Weiyan Y Dong, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|April 29, 2015
A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission eventsAndrea D Olmstead, Jeffrey B Joy, Vincent Montoya, et al.
Drug and Alcohol Dependence|May 16, 2015
Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, CanadaEvan B Cunningham, Brendan Jacka, Kora DeBeck, et al.
Viruses|November 11, 2022
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort StudyAndrea D Olmstead, Aidan M Nikiforuk, Sydney Schwartz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Pageof 3